Average Co-Inventor Count = 4.27
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (19 from 2,405 patents)
2. Merck + Co., Inc. (4 from 4,770 patents)
23 patents:
1. 10000499 - Methyl diazepane orexin receptor antagonists
2. 9994570 - Bridged diazepane orexin receptor antagonists
3. 9987255 - 5,5-bicyclic oxazole orexin receptor antagonists
4. 9732077 - Diazepane orexin receptor antagonists
5. 9663513 - Pyrimidine PDE10 inhibitors
6. 9428492 - Secondary alcohol substituted triazoles as PDE10 inhibitors
7. 9365562 - 1,3 substituted azetidine PDE10 inhibitors
8. 9359348 - Cyclopropyl imidazopyridine PDE10 inhibitors
9. 9353104 - Substituted pyridizinone derivatives as PDE10 inhibitors
10. 9284302 - Cyclobutyl benzimidazoles as PDE 10 inhibitors
11. 9273033 - Substituted pyridone derivatives as PDE10 inhibitors
12. 9200001 - Triazolyl PDE10 inhibitors
13. 8871796 - Diaryl ether derivatives as notch sparing gamma secretase inhibitors
14. 8637513 - Heterocycle phenyl amide T-type calcium channel antagonists
15. 8592457 - Isonicotinamide orexin receptor antagonists